Community Bank of Raymore’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.27M Sell
45,220
-9,910
-18% -$264K 0.85% 34
2025
Q4
$1.37M Buy
55,130
+3,000
+6% +$75.7K 0.93% 28
2025
Q3
$1.33M Buy
52,130
+3,000
+6% +$74K 0.92% 30
2025
Q2
$1.19M Buy
49,130
+8,500
+21% +$198K 0.88% 32
2025
Q1
$1.03M Buy
40,630
+1,360
+3% +$35.6K 0.83% 34
2024
Q4
$1.04M Buy
39,270
+6,155
+19% +$167K 0.82% 34
2024
Q3
$958K Hold
33,115
0.72% 35
2024
Q2
$927K Sell
33,115
-20,695
-38% -$570K 0.72% 36
2024
Q1
$1.49M Buy
53,810
+5,700
+12% +$158K 0.7% 37
2023
Q4
$1.39M Buy
48,110
+2,310
+5% +$69.8K 0.61% 40
2023
Q3
$1.52M Buy
45,800
+2,950
+7% +$104K 0.71% 38
2023
Q2
$1.57M Buy
42,850
+8,570
+25% +$334K 0.68% 37
2023
Q1
$1.4M Buy
34,280
+8,480
+33% +$366K 0.54% 37
2022
Q4
$1.32M Buy
25,800
+18,830
+270% +$903K 0.48% 38
2022
Q3
$305K Buy
+6,970
New +$339K 0.1% 51

Other funds holding PFE

Community Bank of Raymore's PFE Position: Q1 2026 in Review

Community Bank of Raymore reduced its Pfizer (PFE) stake by 18% in Q1 2026, selling an estimated $264K and leaving 45,220 shares worth $1.27M. The position accounts for 0.85% of the portfolio, ranked #34.

Community Bank of Raymore first reported a position in PFE in Q3 2022 and has held it in 15 quarters since. The position peaked at $1.57M in Q2 2023. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Community Bank of Raymore held 45,220 shares of Pfizer worth $1.27M as of Q1 2026.
  • Community Bank of Raymore sold 9,910 Pfizer shares in Q1 2026, an estimated $264K.
  • Pfizer made up 0.85% of Community Bank of Raymore's portfolio in Q1 2026, its #34 holding.
  • Community Bank of Raymore first reported a position in Pfizer in Q3 2022 and has held it in 15 quarters since.
  • Community Bank of Raymore's Pfizer position peaked at $1.57M in Q2 2023.
  • 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Community Bank of Raymore's 13F filing for Q1 2026, filed 17 Apr 2026.